Nasdaq

Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients

HERTFORDSHIRE, England and PITTSBURGH and BANGALORE, India, July 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that the Drug Controller General of India (DCGI) has approved its ...
Business Wire

Lyophilized Drugs, Reconstitution Devices and Injection Market Report 2024 - The Importance of Technology and Regulatory Factors on Commercialization and Market Access ...

DUBLIN--(BUSINESS WIRE)--The "Lyophilized Drugs, Reconstitution Devices and Injection Markets: Products, Markets, Therapeutics, Strategies & Forecasts" report has been added to ...
Monthly Prescribing Reference

Nucala Approved for Self-Administration Via Autoinjector, Prefilled Safety Syringe

Previously, the treatment had only been available as a lyophilized powder for reconstitution that required administration by a healthcare professional. The Food and Drug Administration has approved ...
Monthly Prescribing Reference

Zevtera Availability Provides New Option for Serious Bacterial Infections

Zevtera is supplied as a single-dose vial containing 667mg of ceftobiprole medocaril sodium as a lyophilized powder for reconstitution. Zevtera ® (ceftobiprole medocaril sodium for injection) is now ...
Reuters

Mylan Secures Regulatory Approval For Remdesivir Lyophilized Powder For Injection 100 Mg/Vial In India

* MYLAN NV - DRUG IS APPROVED FOR TREATMENT OF SUSPECTED OR LABORATORY CONFIRMED INCIDENCES OF COVID-19 IN ADULTS AND CHILDREN Source text for Eikon: Further company coverage: ...